PRESS RELEASES

11/30/17

GENEWIZ Honored with Two Top New Jersey Business Awards

South Plainfield, N.J. — November 2017 — Leading global genomics service provider, GENEWIZ, was recently recognized by the New Jersey Business & Industry Association’s 2017 Awards for Excellence with the Outstanding Employer Award. This comes on the heels of being named to NJBIZ’s list of the 50 Fastest Growing Companies in New Jersey for the fifth year in the row.

11/15/2017

PacBio and GENEWIZ Announce Winner of the 2017 AACR SMRT Grant

Menlo Park, CA and South Plainfield, NJ – Pacific Biosciences of California, Inc. (NASDAQ: PACB), the leader in long-read sequencing, and GENEWIZ, the leading global genomics service provider, announce that Andrew Ludlow, Ph.D. from the University of Michigan, is the winner of the AACR SMRT® Grant. With this SMRT Grant, Dr. Ludlow will receive Iso-Seq® analysis on the PacBio® Sequel® System at the GENEWIZ laboratory to further his investigation to understand the splicing of transcripts regulated by NOVA1 in lung cancer cells.

10/17/2017

GENEWIZ Launches Expanded Next Generation Sequencing Services Including Quick-Turn Amplicon-EZ and Long-Read Amplicon Sequencing at ASHG

South Plainfield, N.J. and Orlando, Fla. (ASHG17, Booth #323) — October 17, 2017 — Leading global genomics service provider, GENEWIZ, launches CLIA Sanger sequencing and new NGS amplicon sequencing, at booth #323 during The American Society of Human Genomics (ASHG) Annual Meeting. ASHG is the largest gathering of human genetics professionals in the world and takes place this October 17-21, 2017 in Orlando.

3/28/2017

GENEWIZ TO LAUNCH SINGLE-CELL RNA-SEQ SERVICES AT AACR

South Plainfield, N.J. and Washington, D.C. (AACR17, Booth #3431). — Mar 28, 2017 — Leading global genomics service provider, GENEWIZ, will launch single-cell sequencing during the American Association for Cancer Research (AACR) Annual Meeting at the Walter E. Washington Convention Center in Washington, D.C., April 1-5, 2017. Single-Cell RNA-Seq allows researchers to perform differential gene expression of thousands of cells at the individual level..

11/15/2016

GENEWIZ CHOSEN FOR THE INC. 5000 LIST OF FASTEST-GROWING PRIVATE COMPANIES FOR THIRD YEAR IN A ROW

South Plainfield, NJ – November 15, 2016 – Leading global genomics service provider, GENEWIZ, was recently named to the Inc. 5000 list of fastest-growing private companies in the United States for the third consecutive year.

10/24/2016

Frost & Sullivan Applauds GENEWIZ's Commitment to Providing Cutting-edge Services in the Life Science Research Services Market

MOUNTAIN VIEW, Calif. — Oct 24, 2016 — Based on its recent analysis of the life science research services market, Frost & Sullivan recognizes GENEWIZ with the 2016 North America Frost & Sullivan Company of the Year Award. GENEWIZ's strategic decisions to reinvest in itself and expand its infrastructure, geographies, and customer channels have enabled it to emerge as a leader in this intensely competitive market. Its recent acquisition of Beckman Coulter Genomics (BCG) and implementation of multiple new genomics platforms demonstrate its commitment to growth and delivering cutting-edge research services using various genomics technologies and techniques.

10/05/2016


GENEWIZ Implements Edico Genome DRAGEN Processors to Accelerate Analysis of Big Data Generated by New High-Throughput, Next-Generation Sequencing Platforms

SOUTH PLAINFIELD, NJ and SAN DIEGO – Oct. 5, 2016GENEWIZ, a leading global genomics services provider, today announced it will implement multiple Edico Genome DRAGEN™ Bio-IT processors to accelerate the analysis of massive volumes of genomic data generated by its high-throughput sequencing platforms. GENEWIZ’s already quick turnaround times are expected to be reduced by days for large next-generation sequencing (NGS) data sets, without sacrificing data quality or integrity.

09/27/2016


GRAND OPENING OF NEW GENEWIZ CAMBRIDGE LABORATORY

South Plainfield, NJ and Boston – September 27, 2016 - GENEWIZ, a leading global genomics services provider, opened a new flagship laboratory in Cambridge, MA on Wednesday September 21st 2016. The addition of Oligo Synthesis and Plasmid Preparation services to the new Cambridge laboratory enhances the local Boston Sanger DNA sequencing services, providing increased speed and convenience to the customer.
04/15/2016


GENEWIZ Expands High Throughput Sequencing Capabilities with Investment in Multiple Platforms

South Plainfield, NJ – April 15, 2016 –GENEWIZ, a leading global genomics services provider, announced today it has acquired multiple high-throughput sequencing (also known as Next Generation Sequencing (NGS)) platforms including the Illumina HiSeq X Ten, PacBio Sequel, and 10x Genomics Chromium. The addition of these cutting-edge systems strengthens the scope of the NGS services GENEWIZ offers the scientific community worldwide.
02/25/2016


GENEWIZ Completes Key Gene Synthesis of Zika Virus

GENEWIZ, a leading global genomics services provider, recently collaborated with the National Key Laboratory of Biotherapy of Sichuan University in China, to synthesize the key genes of the Zika virus as part of expedited research and development into drugs and vaccines to combat the infectious disease.
01/14/2016


Article Authored by GENEWIZ Researchers Published in PLOS ONE

GENEWIZ, a leading global genomics services provider, announced today that a manuscript authored by its researchers has been published in PLOS ONE

1/11/16

Global Genomics Company, GENEWIZ, Receives Investment

GENEWIZ, a leading global genomics services provider, announced today that it had received an investment to support its growth activities. The terms of the investment were not disclosed. The financing was led by OrbiMed, a healthcare-dedicated investment firm, and participated in by Ampersand Capital Partners and Prime Value Capital Management (PVCM).
12/21/15

GENEWIZ Acquires the Genomic Services Business of Beckman Coulter

Leading global genomics service provider, GENEWIZ, has signed a definitive agreement to acquire the genomic services business of Beckman Coulter, which delivers expert genomics sequencing solutions to healthcare businesses, as well as academic and government institutions worldwide (GS).
10/28/15

GENEWIZ Joins Inc. 5000 List of Fastest-growing Private Companies for Second Consecutive Year

Leading global genomics service provider, GENEWIZ, has been named to the Inc. 5000 for the second year in a row. The 34th annual Inc. 5000 is Inc. magazine’s exclusive ranking of the fastest-growing private companies in the United States.
10/27/15

GENEWIZ to Present at PEGS Europe Protein & Antibody Summit Company to Showcase Antibody Workflow Solutions, Including FuzeSeq™

Leading global genomics service provider, GENEWIZ, will discuss its antibody workflow solutions at the Seventh Annual PEGS Europe Protein & Antibody Engineering Summit, November 2-6 in Lisbon, Portugal.
10/21/15

GENEWIZ and the BIRD Foundation to Present a Case Study on International Funding Collaboration at BioNJ

Leading global genomics service provider, GENEWIZ, along with the Israel-U.S. Binational Industrial Research and Development Foundation (BIRD Foundation)...
05/28/15

GENEWIZ announces partnership with Hy Laboratories Ltd. (hylabs)

Leading global genomics service provider, GENEWIZ, announced a partnership with Hy Laboratories Ltd. (hylabs), Israel’s premier provider of microbiology and molecular and cell biology products and services...

04/15/15

GENEWIZ to Highlight FuzeSeq™ Antibody, Cancer Panels at the American Association for Cancer Research Annual Meeting

Leading global genomics company, GENEWIZ, is proud to feature FuzeSeq™ Antibody, among other genomics services and solutions...
04/14/15

GENEWIZ Announces Japanese Expansion & Appointment of Noboru Kagimoto, Japan Country Manager

Leading global genomics service company, GENEWIZ, announced expansion of its Japanese operations with the appointment of Noboru Kagimoto...
03/18/15

GENEWIZ Launches Novel Antibody Sequencing Methodology, FuzeSeq™

Leading global genomics service company, GENEWIZ, today announced the launch of FuzeSeq™ Antibody Sequencing, a proprietary methodology that optimizes...
11/18/14

NJBIZ Ranks GENEWIZ, Inc. #22 Among New Jersey’s 50 Fastest Growing Companies

Leading global genomics service company, GENEWIZ, Inc., was honored by NJBIZ as the 22nd fastest growing company in New Jersey...
08/13/14

GENEWIZ, Inc. Completes Key Gene Synthesis of Ebola Virus in Record Time

Leading global genomics service company, GENEWIZ, Inc., was called upon once again by the China CDC...
06/16/14

Lt. Governor Kim Guadagno Celebrates Expansion of GENEWIZ, Inc. Global Headquarters in South Plainfield

Lt. Governor Kim Guadagno today joined officials from GENEWIZ, Inc. to mark the company’s 15th anniversary during a ribbon cutting ceremony...
04/09/14

GENEWIZ, Inc. Launches Comprehensive Pharmacogenomics Test PGxOne™

GENEWIZ, Inc. today announced the launch of PGxOne™, a new, comprehensive pharmacogenomics test that provides clinically relevant data for personalized patient treatment...
03/31/14

GENEWIZ, Inc. to Showcase Next Generation Sequencing & Gene Synthesis Solutions at the 2014 Analytica Conference

GENEWIZ, Inc. is proud to participate in the Analytica Conference in Munich, Germany...

12/18/13

GENEWIZ, Inc. Announces Illumina CSPro™ Certification for Next Generation Sequencing

GENEWIZ, Inc. has achieved Illumina CSPro™ certification for next generation sequencing...
11/25/13

NJBIZ Ranks GENEWIZ, Inc. #27 Among New Jersey’s Fifty Fastest Growing Companies

GENEWIZ, Inc. was honored by NJBIZ as the 27th fastest growing company in New Jersey...
11/19/13
10/22/13

GENEWIZ, Inc. Announces European Expansion & Appointment of Biserka Bacic-Toplek, Sales Executive

GENEWIZ, Inc. today announced expansion of its European operations with the introduction of GENEWIZ Germany...
10/10/13

ISBioTech Fall Meeting: Featured Presentation by Dr. Jeffrey A. Shaman

GENEWIZ, Inc. will join the ISBioTech First Fall Meeting next week in Rosslyn, Virginia, with a featured presentation...
10/07/13

GENEWIZ, Inc. Launches Ion Proton™ Services as Ion AmpliSeq™ Exome Certified Service Provider

GENEWIZ, Inc. has now become an Ion AmpliSeq™ Exome Certified Service Provider...
10/02/13

NJBIZ Honors New Jersey’s 50 Fastest Growing Companies

GENEWIZ, Inc. has been named one of New Jersey’s 50 Fastest Growing Companies...
09/19/13

Health Briefs with Terry Bradshaw Features GENEWIZ, Inc.

The producers of Health Briefs with Terry Bradshaw are pleased to announce that GENEWIZ, Inc. will be featured...
07/30/13

GENEWIZ, Inc. Announces Collaboration with BeiGene, Ltd.

GENEWIZ, Inc. announced a collaboration with biotechnology company BeiGene...
06/27/13

GENEWIZ, Inc. and the John Theurer Cancer Center at Hackensack University Medical Center Announce Collaboration to Advance Ovarian Cancer Biomarker Discovery

GENEWIZ, Inc. and the John Theurer Cancer Center at Hackensack University Medical Center today announced a collaboration...
06/26/13

GENEWIZ, Inc. Announces Collaboration with KeyTest Diagnostics

GENEWIZ, Inc. a collaboration with KeyTest Diagnostics to foster...
05/29/13

GENEWIZ, Inc. Announces U.S. Expansion with San Francisco Laboratory Opening

GENEWIZ, Inc. announced expansion of its U.S. laboratory facilities...
04/09/13

GENEWIZ, Inc. Completes Key Gene Synthesis of H7N9 Influenza Virus in Four Days

Leading global genomics service company, GENEWIZ, Inc., synthesized and delivered key genes of the H7N9 influenza virus in record time...
04/07/13

GENEWIZ, Inc. Launches OncoGxOne™ Discovery Cancer Panels

GENEWIZ, Inc., leading global genomics service provider, announced the launch of OncoGxOne™ Discovery cancer panels...
03/20/13

GENEWIZ, Inc. Receives CAP Accreditation

Leading global genomics service company, GENEWIZ, Inc., announced accreditation from the College of American Pathologists (CAP)...
02/18/13

GENEWIZ, Inc. Expands Next Generation Sequencing Services with Exome Sequencing

GENEWIZ, Inc. announces expansion of their Next Generation Sequencing service portfolio to include exome sequencing...
01/14/13

GENEWIZ Highlights Next Generation Sequencing Capabilities at Plant & Animal Genome XXI

GENEWIZ, Inc. is proud to be participating in the Plant & Animal Genome XXI Conference this week in San Diego...
12/27/12

Advancing Biotechnology in China: GENEWIZ Gene Synthesis

GENEWIZ, Inc. , is highlighted as a top CRO with entrepreneurial leadership by BioBAY in Nature Biotechnology and Nature Reviews Drug Discovery Biopharma Dealmakers...
12/19/12

Nature Biotechnology: Spotlight on GENEWIZ

GENEWIZ, Inc. is featured in this month’s Nature Biotechnology and Nature Reviews Drug Discovery...
11/30/12

GENEWIZ, Inc. Expands Next Generation Sequencing Services with Cancer Panels

GENEWIZ, Inc. announces expansion of their Next Generation Sequencing service portfolio to include Cancer Panels...
06/18/12

GENEWIZ, Inc. Announces CLIA Certification

GENEWIZ, Inc. received CLIA Licensure and Certificate of Registration from the State of New Jersey...
12/07/11

NJBIZ Names GENEWIZ, Inc. 2011 Business of the Year

GENEWIZ, Inc. was named the 2011 Business of the Year by NJBIZ on Monday, December 5...
11/16/11

NJBIZ Ranks GENEWIZ, Inc. #28 Among Fifty Fastest Growing Companies

GENEWIZ, Inc. was honored by NJBIZ as one of the 2011 Fifty Fastest Growing Companies on Monday evening, November 14...
10/24/11

NJBIZ Honors GENEWIZ, Inc. with New Jersey's Top Businesses and Business Leaders

GENEWIZ, Inc. has been named a finalist for the 2011 NJBIZ Business of the Year Award...
10/20/11

GENEWIZ Named Recipient of NJBIA Award for Excellence

GENEWIZ, Inc. was honored by the New Jersey Business & Industry Association 2011 Award for Excellence for Business Expansion...
10/04/11

GENEWIZ, Inc. Announces European Expansion & Appointment of European Business Development Manager, Andre Kotze

GENEWIZ, Inc. announced European expansion with the launch of the GENEWIZ European Office...
08/01/11

GENEWIZ, Inc. Earns ISO 9001:2008 Quality Management Certification

GENEWIZ, Inc. recently received Quality Management System certification from the International Organization for Standardization (ISO) for their Suzhou, China operation...
06/01/11

GENEWIZ, Inc. and Biomatters Announce Strategic Partnership to Align DNA-Based Services and Analysis Software

GENEWIZ, Inc., the #1 provider of Sanger DNA sequencing services in the United States, announced a strategic partnership to provide integrated solutions to streamline DNA-based services from ordering to data analysis...
03/07/11

GENEWIZ, Inc., Leader in DNA Sequencing & Gene Synthesis, Launches New Online Account Management System, GeneGroupTM

GENEWIZ, Inc., the #1 provider of Sanger DNA sequencing services in the United States, launched a new online account management system, GeneGroupTM...

06/30/10

GENEWIZ Founders Awarded Ernst & Young Entrepreneur Of The Year 2010 in New Jersey

GENEWIZ, Inc., leader in global DNA services, today announced that Dr. Steve Sun, CEO and Dr. Amy Liao, COO, co-founders of GENEWIZ, Inc. received the Ernst & Young Entrepreneur Of The Year 2010 Award in the Service category for New Jersey...
06/14/10

GENEWIZ, Inc., Leader in DNA Sequencing & Gene Synthesis, Expands GLP-Compliant Regulatory Services

GENEWIZ, Inc. the largest provider of research-based Sanger DNA sequencing services in the United States, today announced an expansion of its Good Laboratory Practices...
05/12/10

GENEWIZ, Inc., Leader in DNA Sequencing & Gene Synthesis, Unveils New Logo

GENEWIZ, Inc. the largest provider of research-based Sanger DNA sequencing in the United States, has introduced an updated logo that emphasizes the company's long-standing commitment to excellence in both science and customer support...
04/22/10

DNA Sequencing and Gene Synthesis CRO Announces “GENEWIZ Goes Green” Program

In honor of the 40th Earth Day, GENEWIZ, Inc. announced its “GENEWIZ Goes Green” program, a series of initiatives to reduce environmental impact and encourage employees to undertake additional, ongoing environmentally friendly projects. As a reminder to celebrate Earth Day, GENEWIZ’s website will change from blue to “green” on April 22, for one week...
03/08/10

GENEWIZ Adds Gene Synthesis Service to Molecular Biology Service Portfolio

GENEWIZ, Inc., a leading provider of DNA services, announced the expansion of its molecular biology portfolio with the addition of Gene Synthesis services. Gene synthesis provides researchers with a time- and cost-saving alternative to molecular cloning...
09/17/09

GENEWIZ Announces DNA Sequencing Webinars

GENEWIZ, Inc., the leading provider of research-based DNA sequencing, has planned a series of webinars in Sepember and October to help biomedical, agricultural...
08/04/09

GENEWIZ Celebrates 10th Anniversary as Leading Provider of DNA Sequencing Services with Appreciation of Customers and Employees

GENEWIZ, Inc. has planned a series of events and announcements to celebrate its 10th Anniversary of providing DNA sequencing, molecular biology and genomic services to academic...